{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P83430",
      "entity_text" : "pBD2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "And in this study, 8 mM l-isoleucine treatment significantly increased the expressions of TLR3, RIG-I, IRF3, MAVS, MDA5, NF-kappaB, IFNbeta, IFNgamma, pBD2, and pBD3 in IPEC-J2 cells (P < 0.05, Figure XREF_FIG A) and significantly enhanced the expressions of TLR3, RIG-I, IRF3, MAVS, MDA5, NF-kappaB, IFNbeta, and pBD2 in 3D4/31 cells (P < 0.05, Figure XREF_FIG B).",
  "reading_complete" : "2020-08-04T11:15:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:13:06Z",
  "trigger" : "enhanced",
  "evidence" : [ "NF-kappaB, IFNbeta, IFNgamma, pBD2, and pBD3 in IPEC-J2 cells (P < 0.05, Figure  XREF_FIG A) and significantly enhanced the expressions of TLR3, RIG-I, IRF3, MAVS, MDA5, NF-kappaB, IFNbeta, and pBD2" ],
  "pmc_id" : "6054962",
  "score" : 0
}